Pharmacological Modulation of Cocaine Effects - 1

National Institutes of Health (NIH)

Status and phase: Completed; Phase 2

Conditions: Cocaine-Related Disorders

Treatments: Drug: Selegiline

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00000201

NIDA-05196-1

R01-05196-1

Details and patient eligibility

About

The purpose of this study is to conduct human laboratory studies of possible cocaine interactions with various potential treatment medications.

Sex: Female

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.